Roche Gets FDA OK for Injectable Version of Breast Cancer Drug

Roche Gets FDA OK for Injectable Version of Breast Cancer Drug

Source: 
Xconomy
snippet: 

A new version of a combination drug marketed by Roche for early-stage and metastatic breast cancer with a specific genetic signature received FDA approval Monday for a formulation that can be delivered in minutes rather than an hour or more.